Alkyl halides and alcohols are two of the most versatile and important classes of organic compounds. They serve as building blocks for the synthesis of a vast array of other molecules, including many pharmaceuticals. This chapter will explore the structure, properties, and reactions that produce alcohols and alkyl halides. We will delve into the mechanisms of key reactions, such as radical halogenation, allylic bromination and the conversion of alcohols to alkyl halides and see how these reactions can be used to create new carbon-carbon and carbon-heteroatom bonds. Understanding the chemistry of alkyl halides and alcohols is crucial not only for a solid foundation in organic chemistry, but also for appreciating the role of these compounds in various fields, from medicine to materials science.
In the subsequent chapter will focus on primarily reactions of alkyl halides (Substitution and Elimination) reactions.
Alkyl halides—molecules where carbon is bonded to chlorine, bromine, or iodine—are famously reactive, a property we'll explore throughout this chapter as we dive into substitution and elimination reactions. But if you look for them as permanent fixtures in prescription drugs, you'll find they are practically nonexistent. Their halogen leaving group makes them aggressive alkylating agents in the body, indiscriminately destroying proteins and DNA.
To harness the electronic perks of a halogen without that toxic leaving-group behavior, medicinal chemists often incorporate stable fluorine-bearing groups, such as a fluoromethyl group. Because the carbon-fluorine bond is exceptionally strong and metabolically bulletproof, it can fine-tune receptor binding and block rapid breakdown by Cytochrome P450 (P450) enzymes. A classic example is seen in anti-inflammatory medications like fluticasone, which uses specialized fluorination to lock in high local potency and metabolic stability.

Consider how this strategy plays out in real-world drug design for respiratory treatments like fluticasone propionate. When managing conditions like severe asthma or chronic inflammation, a drug needs to act locally in the lungs, but if it enters the bloodstream too quickly, P450 enzymes in the liver will tear it apart and trigger unwanted systemic side effects.
Medicinal chemists solved this challenge by incorporating a fluoromethyl thioester group ($\text{-SCH}_2\text{F}$) directly into the molecular framework. While a standard, highly reactive alkyl halide would act as a dangerous alkylating agent, this carefully engineered carbon-fluorine structure resists metabolic destruction by P450s, giving the drug exceptional potency while allowing it to be safely cleared by the body before causing systemic chaos. It’s a masterclass in how understanding carbon-halogen bonding allows us to turn subtle structural tweaks into life-saving treatments.